Cyclic AMP-specific phosphodiesterase inhibitors
US6372777B1 · kind B1 · utility
11Cited by
2References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 11, 2000 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Oct 11, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D207/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pyrrole compounds that are potent and selective inhibitors of PDE4, as well as methods of making the same, are disclosed. Use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated levels of cytokines, as well as central nervous system (CNS) disorders, also is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.